Double Grace International Limited - Net Worth and Insider Trading
Double Grace International Limited Net Worth
The estimated net worth of Double Grace International Limited is at least $567 Million dollars as of 2024-09-25. Double Grace International Limited is the 2101 Beneficial owner of Consun Pharmaceutical Group Ltd and owns about 86,707,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) stock worth over $567 Million. Details can be seen in Double Grace International Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Double Grace International Limited has not made any transactions after 2024-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Double Grace International Limited
Double Grace International Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Double Grace International Limited owns 1 companies in total, including Consun Pharmaceutical Group Ltd (HKSE:01681) .
Insider Ownership Summary of Double Grace International Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2024-06-13 | 2101 Beneficial owner |
Double Grace International Limited Latest Holdings Summary
Double Grace International Limited currently owns a total of 1 stock. Double Grace International Limited owns 86,707,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) as of June 7, 2024, with a value of $567 Million.
Latest Holdings of Double Grace International Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2024-06-07 | 86,707,000 | 6.54 | 567,063,780 |
Holding Weightings of Double Grace International Limited
Double Grace International Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Double Grace International Limited has made a total of 2 transactions in Consun Pharmaceutical Group Ltd (HKSE:01681) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Consun Pharmaceutical Group Ltd is the sale of 41,719,000 shares on June 7, 2024, which brought Double Grace International Limited around $0.
Insider Trading History of Double Grace International Limited
- 1
Double Grace International Limited Trading Performance
GuruFocus tracks the stock performance after each of Double Grace International Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Double Grace International Limited is 0.61%. GuruFocus also compares Double Grace International Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Double Grace International Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Double Grace International Limited's insider trading performs compared to the benchmark.
Performance of Double Grace International Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.43 | | | | | |
| Relative Return to S&P 500(%) | 4.52 | | | | | |
Double Grace International Limited Ownership Network
Double Grace International Limited Owned Company Details
What does Consun Pharmaceutical Group Ltd do?
Who are the key executives at Consun Pharmaceutical Group Ltd?
Double Grace International Limited is the 2101 Beneficial owner of Consun Pharmaceutical Group Ltd. Other key executives at Consun Pharmaceutical Group Ltd include 2101 Beneficial owner Li Qian , 2101 Beneficial owner An Yubao , and 2101 Beneficial owner Central Success Developments Limited .
Consun Pharmaceutical Group Ltd (HKSE:01681) Insider Trades Summary
Over the past 18 months, Double Grace International Limited made 1 insider transaction in Consun Pharmaceutical Group Ltd (HKSE:01681) with a net sale of 0. Other recent insider transactions involving Consun Pharmaceutical Group Ltd (HKSE:01681) include a net sale of 9,219,000 shares made by Li Qian , a net sale of 9,219,000 shares made by An Yubao ,
In summary, during the past 3 months, insiders sold 0 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,438,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,438,000 shares.
Consun Pharmaceutical Group Ltd (HKSE:01681)'s detailed insider trading history can be found in Insider Trading Tracker table.
Consun Pharmaceutical Group Ltd Insider Transactions
Double Grace International Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Double Grace International Limited. Currently GuruFocus does not have mailing address information for Double Grace International Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
